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Abstract
Background: Childhood epilepsy can adversely affect education and employment in addition to health. Previous
studies are small or highly selective producing conflicting results. This retrospective cohort study aims to compare
educational and health outcomes of children receiving antiepileptic medication versus peers.
Methods: Record linkage of Scotland-wide databases covering dispensed prescriptions, acute and psychiatric
hospitalisations, maternity records, deaths, annual pupil census, school absences/exclusions, special educational
needs, school examinations, and (un)employment provided data on 766,244 children attending Scottish schools between
2009 and 2013. Outcomes were adjusted for sociodemographic and maternity confounders and comorbid conditions.
Results: Compared with peers, children on antiepileptic medication were more likely to experience school absence
(Incidence Rate Ratio [IRR] 1.43, 95% CI: 1.38, 1.48), special educational needs (Odds ratio [OR] 9.60, 95% CI: 9.02, 10.23),
achieve the lowest level of attainment (OR 3.43, 95% CI: 2.74, 4.29) be unemployed (OR 1.82, 95% CI: 1.60, 2.07), be
admitted to hospital (Hazard Ratio [HR] 3.56, 95% CI: 3.42, 3.70), and die (HR 22.02, 95% CI: 17.00, 28.53). Absenteeism
partly explained poorer attainment and higher unemployment. Girls and younger children on antiepileptic medication
had higher risk of poor outcomes.
Conclusions: Children on antiepileptic medication fare worse than peers across educational and health outcomes. In
order to reduce school absenteeism and mitigate its effects, children with epilepsy should receive integrated care from
a multidisciplinary team that spans education and healthcare.
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What is known on this subject?
Children who have epilepsy suffer increased morbidity
and mortality and experience deficits in cognitive func-
tion. However, there is conflicting evidence as to
whether their disadvantages extend to poorer school
outcomes.
What this study adds?
This population-wide record linkage study is the largest
to date to investigate a wide range of both educational
and health outcomes in an unselected cohort of children
taking antiepileptic medication compared to their peers.
Background
Epilepsy is a relatively common neurological condition
for which medication is the main intervention to control
seizure activity [1, 2]. In developed countries, such as
Scotland, the childhood prevalence of epilepsy has been
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estimated at 3.2–9.3 per 1000 [3–6] and childhood inci-
dence is highest in the first year of life. [3, 4] Childhood
epilepsy is associated with increased risk of mortality
[7–11] including sudden death in epilepsy (SUDEP) [12]
and suicide [13], as well as morbidity and hospitalisation,
especially due to injury. [14–17] Previous studies have
demonstrated higher mortality rates among children
with epilepsy compared to the general population,
reporting increased risk of death between three and
twenty-fold. [7–11]. However, to the best of our know-
ledge, previous studies have not directly compared chil-
dren with epilepsy to a cohort of their unaffected peers
with respect to all-cause mortality or all cause hospital-
isation. Studies reporting hospitalisations in children
with epilepsy compared to peers have focussed on injury
admissions with associations evident in large studies [14]
but inconclusive findings reported in smaller studies
limited by sample size [15, 18]. Most commonly re-
ported reasons for admission among children with epi-
lepsy include fractures [14–16], head and dental injuries
[15, 16], burns and scalds [14, 15], soft tissue injuries
[16], poisoning [14], drowning and submersion [17] and
self-harm [19].
In addition to poorer health outcomes, several studies
have reported lower academic achievement among chil-
dren with epilepsy compared to their unaffected peers
[20–27], and children with other chronic conditions such
as asthma. [28, 29] However, the majority of these studies
have relied on battery tests, or parental or teacher reports
of school grades [20–22, 24–29] and few have analysed of-
ficial school recorded exam grades [23]. Furthermore, the
evidence for worse academic outcomes is based on rela-
tively few, small sample size studies [21, 22, 26–28, 30]
many of which sampled children attending hospital clinics
[21, 23, 25, 30]. Whether epilepsy does [28, 30, 31] or does
not [21, 22] impact on intelligence is unclear. However,
there is consistent evidence that epilepsy is associated with
learning difficulties [21, 28, 32], reduced cognition [20, 33]
and specific cognitive impairment relating to: attention
[21, 32, 34, 35], memory [21, 31, 32, 36], dexterity [32, 34],
psychomotor speed [31, 34], verbal function [37], execu-
tive function [26, 36], language [21, 32], perception [32],
auditory processing [26], and response inhibition [34].
Children with epilepsy are also more likely to suffer co-
morbid conditions such as attention deficit hyperactivity
disorder (ADHD) and conduct disorders [28, 31, 38,
39], anxiety [28], depression [40–42], low self-esteem
[35, 43] and psychosocial dysfunction [44]. A limited
number of small sample studies have reported higher
rates of school dropout [28], increased use of special
educational services [45] and increased school absen-
teeism [28, 30]; however, to our knowledge, none
have reported school exclusion or unemployment. To
the best of our knowledge, no population-wide studies
have previously investigated associations between epi-
lepsy and school outcomes and no such studies have
been conducted in the UK. This retrospective cohort
study fills several important gaps in the literature by
using record linkage of eight Scotland-wide databases
to study a range of education and health outcomes in
an unselected countrywide cohort of schoolchildren
taking antiepileptic medication compared to their
peers.
Methods
Databases
Individual-level data from four Scotland-wide health da-
tabases and four Scotland-wide education databases
were linked together using linkage methodology de-
scribed previously. [46–48] Health data were provided
by the Information Services Division (ISD) of the Na-
tional Health Service (NHS) and education data were
provided by the Scottish Exchange of Educational Data
(ScotXed). The study cohort comprised singleton chil-
dren born in Scotland who attended a Scottish local au-
thority run school at any point between 2009 and 2013.
The prescribing information system (PIS) collects data
on prescriptions dispensed by community pharmacies or
primary care to Scottish residents. The Scottish Morbid-
ity Record (SMR) 02 maternity database collects mater-
nal and obstetric data pertaining to pregnant mothers’
and outcomes pertaining to their offspring. Acute and
psychiatric hospital admissions are recorded through
SMR01 and SMR04 records respectively, which include
dates of admission and discharge and International Clas-
sification of Diseases (ICD) diagnostic codes. The Na-
tional Records of Scotland collect date and cause of
death from death certificates.
The pupil census, conducted every September by local
authority run primary, secondary and special schools
across Scotland, gathers pupil demographic information
including whether the child has a special educational
need and its type. The Scottish Qualifications Authority
collects school exam results for these schoolchildren.
Absences and exclusions are collected prospectively and
appended to the school census at the end of each school
year. The school leaver database collects information on
whether pupils are in paid/voluntary employment,
higher/further education, or training or are unemployed
six months after leaving school.
Inclusion criteria, definitions and outcomes
Records pertaining to children aged < 4 years or > 19
years in the pupil census were excluded from the ana-
lyses. The final cohort comprised singleton births only
because, for same sex multiple births, we could not be
certain that the correct child had linked (Fig. 1). We
used PIS data to identify children prescribed medication
Fleming et al. BMC Public Health          (2019) 19:595 Page 2 of 12
for epilepsy (any drug from BNF section 4.8), [47, 49]
ADHD (methylphenidate hydrochloride, dexampheta-
mine sulphate, atomoxetine or lisdexamfetamine dime-
sylate), diabetes (insulin) or depression (tricyclic
antidepressant, selective serotonin reuptake inhibitor,
mirtazapine or venlafaxine) on at least one occasion over
the school year and those prescribed medication for
asthma (inhaled corticosteroid and beta agonist both dis-
pensed twice or more over one year). This methodology
has been described previously. [47, 48] The comparison
group (peers) was all other children attending school
over the study period (i.e. children not in receipt of anti-
epileptic medication).
Educational outcomes analysed were annual number
of days absent, annual number of school exclusions, an-
nual record and type of special educational need, leaving
school before 16 years of age, final academic achieve-
ment, and subsequent unemployment. Data on absences
and exclusions were only available for 2009, 2010 and
2012. The last three outcomes were only available for
pupils who left school within the study period.
Special educational need is defined as inability to
benefit from school education without additional help
over and above that normally given to schoolchildren of
the same age. The school census included special educa-
tional need ascribed to intellectual disabilities, learning
difficulties, dyslexia, physical/motor/sensory impairment,
language/speech disorder, autistic spectrum disorder,
physical/mental health conditions and social/emotional/
behavioural difficulties. Recording of more than one was
allowed. An ordinal measure of academic achievement
(low, basic, broad general and high attainment) over the
last three years of school (S4-S6) was derived using the
number of exam awards attained at each level of the
Scottish Credit Qualifications Framework (SCQF). [50]
Leaver destination was analysed as a binary variable
Fig. 1 Number of Pupils Included and Excluded at Each Stage of Data Cleaning
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(education/employment/training or unemployment).
Health outcomes analysed were all-cause hospitalisation,
hospitalisation for injury, poisoning or trauma (ICD-10
codes S00-T98), and all-cause mortality. We had follow
up data on acute and psychiatric hospitalisations and
deaths until September 2014 enabling a mean follow-up
period of 4.3 years (range 1 to 5 years).
In addition to comorbid ADHD, depression, diabetes
or asthma, identified from prescribing data, we adjusted
our analyses for several other potential confounders.
The pupil census recorded children’s sex, age and ethni-
city. General population quintiles of area socioeconomic
deprivation were derived for data zones of residence
(median population 769) using the Scottish Index of
Multiple Deprivation (SIMD) 2012, calculated from 38 in-
dicators across 7 domains (health, housing, employment,
income, crime and education, skills and training, and geo-
graphic access). Retrospective linkage to SMR02 enabled
adjustment for maternal age at delivery, gestation at deliv-
ery, maternal smoking, mode of delivery, 5 min Apgar
score, parity, and derived sex-, gestation-specific birth-
weight centiles.
Statistical analyses
We used chi square tests for categorical data and chi
square tests for trend for ordinal data to compare the
characteristics of children on antiepileptic medication
with their peers. Absences, exclusions and special educa-
tional need were recorded annually and analysed as
yearly outcomes. We used generalised estimating equa-
tions (GEE) to account for correlations between observa-
tions repeated for the same pupil across different years.
[51] We compared different correlation structures using
the user-written quasi-likelihood under the independ-
ence model criterion (QIC) statistic. The lowest trace
QIC indicated the most appropriate structure. [52]
Number of days absent and number of exclusions were
modelled using GEE analyses with a negative binomial
distribution and log link function using number of pos-
sible attendances each year as an offset variable to adjust
for individual exposure time. We modelled special edu-
cational need using GEE analyses with a binomial distri-
bution and logit link. Age at leaving school and
unemployment were analysed using binary logistic re-
gression models and academic attainment was analysed
using generalised ordinal logistic regression. Hospitalisa-
tion and mortality were modelled using Cox propor-
tional hazard models where the assumption of
proportionality held; otherwise, Poisson piecewise re-
gression models were used. Tests for proportional haz-
ards were conducted using the Stata estat phtest
command. These longer-term end-outcomes were sum-
marised and modelled on a pupil, rather than yearly,
basis dependent on whether children had previously
been prescribed epilepsy medication at any point within
the study period. Therefore, longitudinal methods were
not required. These methods have been described previ-
ously. [47, 48] We ran all models unadjusted, then ad-
justed for sociodemographic and maternity confounders
and comorbid conditions: ADHD, depression, asthma
and diabetes. We explored age, sex and deprivation as
potential effect modifiers by firstly testing for statistical
interactions and then undertaking sub-group analyses
where interactions were significant. For academic attain-
ment, we re-ran the multivariate models including ab-
senteeism as a covariate to explore whether it was a
mediator. For unemployment, we re-ran including
both absenteeism and attainment as mediators. We
also re-ran the attainment and unemployment models
excluding children with special educational needs. All
statistical analyses were undertaken using Stata MP
version 14.1.
Approvals
The authors applied for permission to access, link and
analyse these data and undertook mandatory training in
data protection, IT security and information governance.
Therefore, the datasets generated and analysed during
the study are not publicly available. The study was ap-
proved by the National Health Service Privacy Advisory
Committee and covered by a data processing agreement
between Glasgow University and ISD and a data sharing
agreement between Glasgow University and ScotXed.
Results
Between 2009 and 2013, 766,244 singleton children born
in Scotland attended Scottish schools. Antiepileptic
medication was used by 5314 (0.69%); more commonly
by girls (0.72%) than boys (0.67%). Children on antiepi-
leptic medication were more likely to live in deprived
areas, and have mothers who were younger, smoked dur-
ing pregnancy, and experienced pregnancy complica-
tions (Table 1). Compared with their peers, they were
also more likely to be on medication for depression
(8.54% versus 0.64%, P < 0.001) and ADHD (3.33% ver-
sus 0.95%, P < 0.001).
The subgroup analyses of absence and exclusion in-
cluded 702,210 children. Children on antiepileptic medi-
cation had more days absent especially among younger
children and girls. (Table 2). The magnitude of the rela-
tive association decreased with increasing deprivation
(all interactions, P < 0.001): However, this was attribut-
able to greater baseline absenteeism among the most
deprived children not on antiepileptic medication com-
pared to the least deprived (median 11.0 versus 5.5 days).
Among children on antiepileptic medication, absentee-
ism was also higher for children in the most compared
to the least deprived quintile (median 13.5 versus 8.5
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days). Epilepsy was not significantly associated with
number of exclusions from school on univariate analysis
(IRR 1.19, 95% CI: 0.98, 1.44) or after adjusting for con-
founders (IRR 0.89, 95% CI: 0.73, 1.09).
Table 1 Characteristics of Schoolchildren by Presence or
Absence of Treated Epilepsy
No epilepsy Epilepsy P value
N = 760,930 N = 5314
N % N %
Sociodemographic factors
Sex
Male 387,672 50.9 2618 49.3 0.015
Female 373,258 49.1 2696 50.7
Missing 0 0
Deprivation quintile
1 (most deprived) 172,422 22.7 1372 25.8 < 0.001
2 152,434 20.0 1135 21.4
3 146,897 19.3 1027 19.3
4 148,538 19.5 985 18.5
5 (least deprived) 140,049 18.4 791 14.9
Missing 590 4
Ethnic group
White 723,055 96.2 5061 96.2 < 0.001
Asian 17,641 2.3 136 2.6
Black 1956 0.3 9 0.2
Mixed 6684 0.9 44 0.8
Other 2066 0.3 10 0.2
Missing 9528 54
Medication for comorbid conditions
Diabetes 3278 0.4 52 1.0 < 0.001
Asthma 45,397 6.0 503 9.5 < 0.001
ADHD 7236 1.0 177 3.3 < 0.001
Depression 4888 0.6 454 8.5 < 0.001
Maternity factors
Maternal age (years)
≤24 208,289 27.4 1589 29.9 < 0.001
25–29 222,902 29.3 1638 30.8
30–34 215,540 28.3 1395 26.3
≥35 114,187 15.0 692 13.0
Missing 12 0
Maternal smoking
No 487,860 72.4 3254 69.9 < 0.001
Yes 186,387 27.6 1402 30.1
Missing 86,683 658
Parity
0 343,228 45.3 2437 46.0 0.400
1 262,333 34.7 1809 34.2
> 1 151,521 20.0 1049 19.8
Missing 3848 19
Table 1 Characteristics of Schoolchildren by Presence or
Absence of Treated Epilepsy (Continued)
No epilepsy Epilepsy P value
N = 760,930 N = 5314
N % N %
Mode of delivery
SVD 512,788 67.4 3431 64.6 < 0.001
Assisted vaginal 91,039 12.0 618 11.6
Breech vaginal 2211 0.3 22 0.4
Elective CS 57,907 7.6 407 7.7
Emergency CS 96,822 12.7 834 15.7
Other 161 0.0 2 0.0
Missing 2 0
Gestation (weeks)
< 24 27 0.0 2 0.0 < 0.001
24–27 1087 0.1 38 0.7
28–32 6935 0.9 123 2.3
33–36 35,255 4.6 347 6.5
37 37,279 4.9 340 6.4
38 95,243 12.5 749 14.1
39 157,648 20.7 1092 20.6
40 228,958 30.1 1472 27.7
41 170,243 22.4 950 17.9
42 26,934 3.5 190 3.6
43 624 0.1 6 0.1
> 43 140 0.0 0 0.0
Missing 557 5
Sex-gestation-specific birthweight centile
1–3 31,173 4.1 313 5.9 < 0.001
4–10 68,129 9.0 517 9.7
11–20 90,686 11.9 662 12.5
21–80 447,092 58.8 3029 57.1
81–90 64,956 8.5 407 7.7
91–97 40,956 5.4 265 5.0
98–100 16,969 2.2 110 2.1
Missing 969 11
5-min Apgar
1–3 3619 0.5 90 1.7 < 0.001
4–6 7181 1.0 121 2.3
7–10 742,359 98.6 5053 96.0
Missing 7771 50
ADHD attention deficit hyperactivity disorder, N number, SVD spontaneous
vaginal delivery, CS Caesarean section
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Children on antiepileptic medication were more likely
to have special educational needs on univariate analysis
(OR 9.83, 95% CI: 9.29, 10.40) and following adjustment
for sociodemographic and maternity factors (OR 10.11,
95% CI: 9.51, 10.75) and comorbid conditions (OR 9.60,
95% CI: 9.02, 10.23). The associations were stronger in
girls (fully adjusted OR 11.06, 95% CI: 10.13, 12.07) than
boys (fully adjusted OR 8.38, 95% CI: 7.68, 9.15) and
stronger in younger children: < 11 years of age (fully ad-
justed OR 13.15, 95% CI: 11.89, 14.53) compared with >
14 years (fully adjusted OR 7.90, 95% CI: 7.26, 8.59).
The association was stronger in the least deprived
quintile (fully adjusted OR 14.58, 95% CI: 12.40,
17.13) than the most (fully adjusted OR 7.57, 95% CI:
6.73, 8.51); explained by special educational need
among children not on anti-epileptic mediation
already being more common in the most deprived
quintile than the least (all interactions, P < 0.001).
Among children not taking antiepileptic medication,
19.4% of the most deprived quintile had a special
education need compared with 10.2% of the least de-
prived. Among children taking antiepileptic medica-
tion, special education need was still more common
in the most deprived quintile than the least deprived:
60.3% versus 49.9% respectively. Taking antiepileptic
medication was most strongly associated with special
education need due to: a physical health condition
(fully adjusted OR 59.78, 95% CI: 54.59, 65.46), phys-
ical motor disability (fully adjusted OR 55.79, 95% CI:
50.77, 61.30); sensory impairment (fully adjusted OR
29.77, 95% CI: 26.38, 33.59); learning disability (fully
adjusted OR 27.11, 95% CI: 24.95, 29.46); and com-
munication problems (fully adjusted OR 24.25, 95%
CI: 21.91, 26.83).
The subgroup analyses of academic attainment in-
cluded 139,205 children. Children on antiepileptic medi-
cation were significantly more likely to attain the lowest
level of academic achievement univariately (OR 2.58,
95% CI: 2.12, 3.14) and after adjustment for sociodemo-
graphic and maternity factors (OR 4.07, 95% CI: 3.26,
5.08) and comorbid conditions (OR 3.43, 95% CI: 2.74,
4.29). Adjustment for absenteeism, attenuated the asso-
ciation but it remained statistically significant (fully ad-
justed OR 2.73, 95% CI: 2.12, 3.53). The relative impact
was less in the most deprived children (fully adjusted
OR 1.89, 95% CI: 1.43, 2.50) than the least deprived
(fully adjusted OR 6.57, 95% CI: 3.30, 13.07) (interaction,
P = 0.009). However, this was again due to higher abso-
lute risk among unaffected children in deprived areas.
Among children not on antiepileptic medication, 9.51%
in the most deprived quintile achieved the lowest level
of attainment compared with 1.03% in the least deprived.
Among children on antiepileptic medication, low aca-
demic attainment was still more common among de-
prived children: 14.02% versus 6.47% respectively. When
children with special educational need were excluded,
children on antiepileptic medication were still more
likely to attain the lowest level of academic achievement
(fully adjusted OR 2.74, 95% CI: 1.96, 3.84).
Children on antiepileptic medication were less
likely, than their peers, to quit school prior to 16
years of age (26.33% versus 28.83%); fully adjusted
OR 0.83, 95% CI: 0.74, 0.93). However, they were
more likely to be unemployed six months after leav-
ing school univariately (OR 1.85, 95% CI: 1.64, 2.09)
and after adjustment for sociodemographic and ma-
ternity factors (OR 1.99, 95% CI: 1.75, 2.25) and co-
morbid conditions (OR 1.82, 95% CI: 1.60, 2.07). The
association was attenuated, but still present, after ex-
cluding children with special educational need (fully
adjusted OR 1.33, 95% CI: 1.10, 1.61). When attain-
ment was added to the models, it attenuated the as-
sociations and they were no longer statistically
significant either including (fully adjusted 0.92, 95%
CI: 0.73, 1.15, P = 0.448) or excluding (fully adjusted
OR 1.07, 95% CI: 0.81, 1.41, P = 0.636) children with
special educational need. The relative association was
stronger in the least deprived quintile (fully adjusted
OR 2.35, 95% CI: 1.63, 3.37) and was not statistically
significant in the most deprived (fully adjusted OR
1.19, 95% CI: 0.93, 1.53, P = 0.171) (interaction, P <
0.001). Again, this reflected the underlying absolute
risk. Among children not taking antiepileptic medica-
tion, 16.91% of the most deprived quintile were un-
employed following school, compared with only 4.94%
Table 2 Association Between Treated Epilepsy and School
Absence: Overall and by Sex, Age and Area Deprivation
Univariate Multivariablea Multivariableb
IRR 95% CI IRR 95% CI IRR 95% CI
Overall 1.62 1.56,1.67 1.50 1.45,1.55 1.43 1.38,1.48
Boys 1.52 1.45,1.59 1.39 1.33,1.46 1.34 1.28,1.41
Girls 1.72 1.64,1.81 1.61 1.53,1.69 1.51 1.44,1.59
< 11 years 1.70 1.61,1.79 1.66 1.56,1.76 1.63 1.53,1.73
11-14 years 1.49 1.40,1.58 1.51 1.42,1.60 1.44 1.37,1.53
> 14 years 1.36 1.29,1.43 1.37 1.30,1.45 1.25 1.19,1.32
1 (most deprived) 1.29 1.22,1.37 1.23 1.16,1.30 1.18 1.11,1.25
2 1.51 1.40,1.62 1.44 1.35,1.54 1.37 1.28,1.47
3 1.77 1.63,1.91 1.61 1.48,1.75 1.54 1.41,1.67
4 1.83 1.68,1.99 1.63 1.50,1.77 1.54 1.41,1.67
5 (least deprived) 2.01 1.82,2.21 1.81 1.64,1.99 1.70 1.54,1.87
aadjusted for age, sex, deprivation quintile, ethnic group, maternal age,
maternal smoking, parity, mode of delivery, gestation at delivery, sex-
gestation-specific birthweight centile and 5-min Apgar score
balso adjusted for comorbid conditions (diabetes, asthma, attention deficit
hyperactivity disorder and depression)
IRR Incidence Rate Ratio, CI confidence interval
All p < 0.001
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of the least deprived. Among children on antiepileptic
medication, the corresponding figures were 18.54%
and 12.17% respectively.
Over a mean of 4.3 years follow-up (range 1 to 5
years), 157,350 (20.5%) children were hospitalised at
least once. Injury, poisoning or trauma accounted for
16.4% of hospitalisations in children on antiepileptic
medication; 8.2% of children on antiepileptic medication
had at least one hospital admission for injury, poisoning
or trauma compared to 4.4% of their peers. In the Cox
models, children on antiepileptic medication were more
likely to be hospitalised for any cause (fully adjusted HR
3.56, 95% CI: 3.42, 3.70) and because of injury, poisoning
or trauma (fully adjusted HR 1.88, 95% CI: 1.71, 2.07).
However, the assumption of proportional hazards did
not hold in either model (both P < 0.001). Therefore,
Poisson piecewise regression models were run by period
of follow-up (Figs. 2a & 3a) and by age of child at admis-
sion (Figs. 2b & 3b). Children on antiepileptic medica-
tion were at higher risk of hospitalisation throughout
but the risk was highest in the first year after commen-
cing medication (Fig. 2a) and at younger ages (Fig. 2b).
Over follow-up, 491 children died; 81 deaths occurred
among children treated for epilepsy and 410 among their
peers. Among children treated for epilepsy 39.5% of
deaths were attributed to diseases of the nervous system,
23.5% to congenital and chromosomal abnormalities,
and 2.5% to injury. Among their peers, 44.4% of deaths
were attributed to injury, 4.6% to diseases of the nervous
system, and 4.6% to congenital and chromosomal
Fig. 2 Association between Treatment with Antiepileptic Medication and all-cause Hospitalisation. a By Time from Commencement of
Medication. b By Age at Admission. Adjusted for age, sex, deprivation quintile, ethnic group, maternal age, maternal smoking, parity,
mode of delivery, gestation at delivery, sex- gestation-specific birthweight centile, 5-minute Apgar score and comorbid conditions
(diabetes, asthma, attention deficit hyperactivity disorder and depression)
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abnormalities. The risk of death was higher among chil-
dren on antiepileptic medication (fully adjusted HR
22.02, 95% CI: 17.00, 28.53). However, the assumption of
proportional hazards again did not hold (P < 0.001) and,
on Poisson piecewise regression analyses, the increased
risk of death was highest below 14 years of age and
within two years of commencing antiepileptic medica-
tion (Figs. 4a & 4b).
Discussion
Children on antiepileptic medication fared worse than
peers across a wide range of outcomes. In addition to in-
creased hospitalisation and mortality they were at higher
risk of: school absence, special educational need, poorer
examination results and unemployment. Poorer attain-
ment was partly explained by increased absenteeism
and, in turn, explained higher rates of unemployment.
Antiepileptic medication was more common among girls
and had stronger associations with absenteeism and spe-
cial educational need among girls. Younger children, and
those who started medication more recently, also had
higher risk.
Studies have consistently demonstrated higher mortality
among children with epilepsy; ranging from 3 to 20-fold.
[7–11] The most similar study to our own, using data
from 430 general practices covering 5% of the UK popula-
tion, reported an excess risk of similar magnitude to our
study. [7] It is unclear whether higher mortality is re-
stricted to those with severe underlying neurological
Fig. 3 Association between Treatment with Antiepileptic Medication and Hospitalisation for Injury/Poisoning/ Trauma. a By Time from
Commencement of Medication. b By Age at Admission. Adjusted for age, sex, deprivation quintile, ethnic group, maternal age, maternal
smoking, parity, mode of delivery, gestation at delivery, sex- gestation-specific birthweight centile, 5-minute Apgar score and comorbid
conditions (diabetes, asthma, attention deficit hyperactivity disorder and depression)
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conditions, [8] or not. [53] To the best of our knowledge,
ours is the first study to compare all-cause hospitalisations
among children taking antiepileptic medication with a co-
hort of their peers. Whereas previous studies have fo-
cussed specifically on injuries, [14, 15] we also reported
all-cause hospitalisations. Our findings relating to injury
were of comparable magnitude to those reported in a
study using general practice data on 11,934 children pre-
scribed antiepileptic medication and 46,598 matched peers
[14]; however, we also demonstrated an even greater in-
creased risk of all-cause hospitalisation.
A previous review identified 15 small-scale studies of
academic achievement among epileptic children attend-
ing hospital and most used academic battery tests. [20]
A few, small-scale studies, comprising between 73 and
116 children with epilepsy, have demonstrated poorer
school performance. [23–25, 28] All but one [23] relied
on parental or teacher reports of academic performance;
one used sibling controls but did not match or adjust for
gender [28] and two used neither matching or statistical
adjustment to control for any potential confounders. [23,
24] Poorer educational attainment may be due to a num-
ber of mechanisms. Previous studies have produced con-
flicting results on whether epileptic children have lower,
[28, 30, 31] or comparable, [21, 22] intelligence to their
peers; perhaps reflecting heterogeneity in participant se-
lection. Our finding of increased special educational need
is consistent with previous reports of increased learning
difficulties [21, 28, 32], reduced cognitive function [20, 33]
and deficits in: attention [21, 32, 34, 35], memory [21, 31,
Fig. 4 Association between Treatment with Antiepileptic Medication and all-cause Mortality. a By Time from Commencement of Medication. b By
Age at Admission. Adjusted for age, sex, deprivation quintile, ethnic group, maternal age, maternal smoking, parity, mode of delivery, gestation at
delivery, sex- gestation-specific birthweight centile, 5-minute Apgar score and comorbid conditions (diabetes, asthma, attention deficit hyperactivity
disorder and depression)
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32, 36], language [21, 32], psychomotor speed [31, 34],
dexterity [32, 34], perception [32], verbal function [37],
auditory processing [26], response inhibition [34] and ex-
ecutive function. [26, 36] It has been suggested that poorer
attainment may be confounded by, or mediated through,
co-existence of ADHD and other conduct disorders [28,
31, 38, 39], depression, [40–42] anxiety, [28], psychosocial
dysfunction [44] or low self-esteem. [35, 43] Our study
confirmed that children on antiepileptic medication were
more likely to be on medication for depression and
ADHD. However, adjusting for these made little difference
to the effect sizes and we demonstrated that attainment
was lower even among children on antiepileptic medica-
tion who did not have a record of special educational
need.
To the best of our knowledge, ours is the first study to
demonstrate that children on antiepileptic medication
were more likely to be unemployed six months after
leaving school. Absenteeism appeared to partly mediate
both poorer attainment and unemployment. Our finding
of higher rates of absenteeism is consistent with some
[28, 30] but not all [21] previous studies. Conversely, our
finding of lower likelihood of leaving school before 16
years of age contrasts with previous evidence of higher
rates of school dropout. [28]
Our observed associations with absenteeism, special
educational need, hospitalisation and mortality were
stronger in younger children. Epilepsy presenting at an
early age is more likely to be associated with congenital
neurological disability. [54] Also, younger children may
have been diagnosed more recently and we demon-
strated that risk of hospitalisation and death fell with
time as children became stabilised on their medication.
[55] The associations with absenteeism and special edu-
cational need were stronger in girls than boys. This find-
ing requires corroboration and further exploration.
Ours was a large, non-selective study that covered
the whole of Scotland. Ascertainment using school, ra-
ther than health, records ensured children with well
controlled epilepsy were not excluded from the study.
Use of antiepileptic medication is an indirect method
of ascertaining epilepsy. Compared with self, parental
or teacher report it is more objective and less prone to
bias. Reliance on parental or teacher report may in-
clude children who had a single seizure, are not yet di-
agnosed with epilepsy, or do not have it. Since
medication is the main intervention to control seizures
incomplete ascertainment should be low. However, 30–
43% of children may not comply with antiepileptic
medication by discontinuing therapy within two years
[56]. Previous studies using medication as a proxy
measure of epilepsy have relied on issued prescriptions.
[7, 14] Our data on encashed prescriptions are more
likely to reflect actual usage.
The large study population was sufficiently powered
to enable us to test for statistical interactions and
conduct sub-group analyses, and we were able to ana-
lyse a wide range of educational and health outcomes
in the same cohort. We could ensure that use of anti-
epileptic medication predated education and health
outcomes and we adjusted for a wide range of poten-
tial confounders; however, residual confounding is
possible in any observational study. Whilst our study
only included children attending local authority main-
tained schools, only 5% of children in Scotland attend
private schools. We could not link 12% of schoolchil-
dren to their maternity records; however, this is con-
sistent with the 11% of residents in Scotland aged 5–
19 years who, according to the 2011 Scottish Census,
were born out with Scotland. The prevalence of anti-
epileptic medication use among linked and unlinked
pupils was 0.6% and 0.7% respectively, suggesting that
bias was unlikely. Whilst our study used administra-
tive databases established for other purposes, these
datasets undergo strict quality assurance. We used
probabilistic record linkage to match education and
health records together and these methods have pre-
viously been validated and shown to be 99% accurate
for singletons births. [46] A limitation of this study is
that we identified cases of epilepsy based on adminis-
tration of anti epileptic drugs, and it is not possible
to deduce the type or severity of epilepsy from this
information because clinicians tend to prescribe the
most general anticonvulsant with the widest spectrum
of activity. It is however likely that the educational
and health outcomes associated with epilepsy may
vary by type and severity of epilepsy and this merits
further investigation in future studies where this in-
formation is available.
Conclusions
Children on antiepileptic medication fared worse than
peers across a wide range of outcomes. In addition to in-
creased hospitalisation and mortality they were at higher
risk of: school absence, special educational need, poorer
examination results and unemployment. Poorer attain-
ment was partly explained by increased absenteeism
and, in turn, explained higher rates of unemployment. In
order to reduce school absenteeism and mitigate its ef-
fects, children with epilepsy should receive integrated
care from a multidisciplinary team covering physicians,
teachers, parents, educational psychologists, and social
services as appropriate. [57, 58] Their management
should extend beyond healthcare to a programme of
school-based interventions such as prevention of trig-
gers, a seizure plan, social and emotional support, adap-
tation of teaching methods, resources and exams, and
inclusion of classmates in cooperative learning. [58]
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